Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma

Resistance to therapy is one of the major factors that contribute to dismal survival statistics in pancreatic cancer. While there are many tumor intrinsic and tumor microenvironment driven factors that contribute to therapy resistance, whether pre-existing metabolic diseases like type 2 diabetes (T2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesh, Kousik, Mendez, Roberto, Abdelrahman, Leila, Banerjee, Santanu, Banerjee, Sulagna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092523/
https://www.ncbi.nlm.nih.gov/pubmed/32204699
http://dx.doi.org/10.1186/s12934-020-01330-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092523/
https://www.ncbi.nlm.nih.gov/pubmed/32204699
http://dx.doi.org/10.1186/s12934-020-01330-3

Ejemplares similares